UBS Group’s UpHealth, Inc. UPH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-1,817
Closed -$1.78K 10575
2023
Q3
$1.78K Buy
1,817
+1,217
+203% +$1.78K ﹤0.01% 7831
2023
Q2
$1.13K Sell
600
-6,848
-92% -$11.3K ﹤0.01% 8008
2023
Q1
$11.1K Buy
7,448
+6,098
+452% +$13.5K ﹤0.01% 7529
2022
Q4
$2.2K Sell
1,350
-533
-28% -$2.08K ﹤0.01% 9716
2022
Q3
$10K Buy
1,883
+533
+39% +$3.19K ﹤0.01% 8538
2022
Q2
$8K Hold
1,350
﹤0.01% 8419
2022
Q1
$16K Sell
1,350
-1,405
-51% -$31.1K ﹤0.01% 7794
2021
Q4
$62K Buy
+2,755
New +$63.7K ﹤0.01% 6732
2021
Q2
Sell
-4,816
Closed -$483K 10117
2021
Q1
$483K Buy
4,816
+404
+9% +$41.8K ﹤0.01% 4896
2020
Q4
$483K Buy
+4,412
New +$454K ﹤0.01% 4624
2020
Q1
Sell
-5,670
Closed -$564K 8591
2019
Q4
$564K Buy
+5,670
New +$560K ﹤0.01% 4731

Other funds holding UPH

UBS Group's UPH Position: Q4 2023 in Review

UBS Group sold out of UpHealth, Inc. (UPH) in Q4 2023, closing a stake of 1,817 shares — an estimated $1.78K sold.

UBS Group first reported a position in UPH in Q4 2019 and held it in 11 quarters. The position peaked at $564K in Q4 2019. 5 funds tracked by Wall St. Rank hold UPH as of Q4 2023.

  • UBS Group reported no remaining UpHealth, Inc. position as of Q4 2023 after selling out during the quarter.
  • UBS Group sold 1,817 UpHealth, Inc. shares in Q4 2023, an estimated $1.78K.
  • UBS Group first reported a position in UpHealth, Inc. in Q4 2019 and held it in 11 quarters.
  • UBS Group's UpHealth, Inc. position peaked at $564K in Q4 2019.
  • 5 funds tracked by Wall St. Rank held UpHealth, Inc. as of Q4 2023.

Based on UBS Group's 13F filing for Q4 2023, filed 9 Feb 2024.